Quanome Technologies has entered an all-stock deal to acquire a 5% stake in QAI Labs, an early-stage life sciences company developing NOVA-3, an AI and quantum computing-based platform for discovering multi-specific antibodies. This strategic investment aims to advance Quanome's Quantum Life Sciences strategy by accelerating molecular discovery and improving drug candidate selection. QAI Labs remains pre-commercial, with its platform still requiring lab validation and regulatory approval. The collaboration will focus on integrating AI and quantum methods to streamline drug discovery and enhance research efficiency.
Quanome's strategic investment in QAI Labs is the subject, with Pluang's Health sector data provided as context. As of Nov 09, 2026 19:41 WIB, among 150 priced Health-sector US stocks tradable on Pluang, 121 rose and 18 fell today. Notable movers include IONS at USD 31.20 with a -20.85% change and a typical hold time of 14 days, IBRX at USD 7.49 down 13.26%, and ABEO at USD 3.65 down 12.47%.
Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...
Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...
Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...
ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...
